Ms. Jing DiPiero, Founder and CEO of DPR Consulting, LLC, was appointed board director at WSCRC’s board meeting on May 3, 2018. Ms. DiPiero is chair of WSCRC’s “Healthcare in China” working group.
Jing DiPiero grew up in Beijing, China, received her MBA degree and CPA designation in the United States along with extended experience in finance, hitech and management. She is the founder and CEO of DPR Consulting, LLC, an organization established by industry leaders in healthcare and global business. It introduces, educates and offers comprehensive medical solutions to Chinese patients, medical practitioners and administrators. It also works with Chinese hospitals and local governments in the field of medicine, innovation and health. DPR has partnered with the National Health and Family Planning Commission in medical exchanges that include the oncology conference co-hosted by DPR and Seattle Cancer Care Alliance in China. As a believer of medical innovation and scientific advancement, DPR has been working with technology companies in Seattle on application of AR technology in medical education and HIMSS EMR system development.
DPR successfully host another year of the Precision Medicine Conference in China in 2018. This year’s conference was co-hosted by Suzhou Municipal Hospital with over 200 oncologists from Suzhou, Nanjing, Shanghai, and many other cities in attendance. President of Jiangsu Providence Medical Association, Ms. Yonghong Wang, Director of Health Commission in Suzhou, Dr. Weiliang Tan, Dr. Jennie Crews, medical director of Seattle Cancer Care Alliance (SCCA), and DPR founder, CEO, Jing DiPiero delivered welcome speeches.
A strong team of oncologists, radiologist and oncology surgeon from SCCA spoke at the conference with leading oncologists from China about solid tumor, cancer prevention, diagnosis and treatment. Mock tumor board and TedX on lung cancer were among the highlights of the two-day conference.
DPR currently with an office in Beijing is in the process of adding 2-4 offices in Southeast coastal cities this year to better service individual patients, hospitals, medical school and companies in the space of Medicine, Health and Innovation in China.
